ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 532 shares, the number of shares held increased 4.07% compared to the previous period and now represents 0.86% of the total position.

ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 488,110 shares, the number of shares held increased 4.23% compared to the previous period and now represents 7.25% of the total position.

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 101,513 shares, the number of shares held increased 0.83% compared to the previous period and now represents 2.15% of the total position.

ARKG Investment Tracker position change: Decreased position in Regeneron Pharmaceuticals by 238 shares, the number of shares held decreased 1.79% compared to the previous period and now represents 0.86% of the total position.

ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 17,652 shares, the number of shares held increased 0.62% compared to the previous period and now represents 3.6% of the total position.

ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 89,915 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 7.46% of the total position.

ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 91,490 shares, the number of shares held decreased 0.76% compared to the previous period and now represents 2.28% of the total position.

ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 38,235 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 6.34% of the total position.

ARKG Investment Tracker position change: Decreased position in Veeva by 119 shares, the number of shares held decreased 0.099% compared to the previous period and now represents 2.21% of the total position.

ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 49,997 shares, the number of shares held decreased 1.86% compared to the previous period and now represents 3.5% of the total position.

ARKG Investment Tracker position change: Decreased position in Veeva by 3,975 shares, the number of shares held decreased 4.94% compared to the previous period and now represents 1.58% of the total position.

ARKG Investment Tracker position change: Decreased position in Illumina by 550 shares, the number of shares held decreased 0.54% compared to the previous period and now represents 1.23% of the total position.

ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 68 shares, the number of shares held increased 0.2% compared to the previous period and now represents 1.3% of the total position.

ARKG Investment Tracker position change: Decreased position in Veeva by 1,209 shares, the number of shares held decreased 1.4% compared to the previous period and now represents 1.77% of the total position.

ARKG Investment Tracker position change: Decreased position in Veracyte by 44,312 shares, the number of shares held decreased 3.02% compared to the previous period and now represents 5.21% of the total position.

ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 496,698 shares, the number of shares held increased 4.23% compared to the previous period and now represents 2.08% of the total position.

ARKG Investment Tracker position change: Decreased position in Veeva by 2,697 shares, the number of shares held decreased 3.02% compared to the previous period and now represents 1.71% of the total position.

ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 70,557 shares, the number of shares held decreased 3.02% compared to the previous period and now represents 4% of the total position.

ARKG Investment Tracker position change: Decreased position in Veracyte by 25,398 shares, the number of shares held decreased 1.86% compared to the previous period and now represents 5.29% of the total position.

ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 40,817 shares, the number of shares held decreased 1.86% compared to the previous period and now represents 9.07% of the total position.